Study shows link between erectile dysfunction drugs and reduced risk of Alzheimer’s

The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer's disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that erectile dysfunction drugs reduce the risk of Alzheimer's disease. It only shows an association.

Erectile dysfunction drugs, which work by dilating blood vessels to allow more blood to flow through, were first developed to treat high blood pressure. A new study suggests that the drugs may be tied to a reduced risk of Alzheimer's disease.

Although we're making progress with the new treatments for Alzheimer's disease that work to clear amyloid plaques in the brain for people with early stages of the disease, we desperately need treatments that can prevent or delay the development of Alzheimer's disease. These results are encouraging and warrant further research."

Ruth Brauer, PhD, study author of the University College London, UK

The study involved 269,725 male participants with an average age of 59 who were newly diagnosed with erectile dysfunction. Participants did not have any memory or thinking problems at the start of the study. They were then followed for an average of five years. The study compared the 55% of the participants who had prescriptions for erectile dysfunction drugs to the 45% who did not have prescriptions.

During the study, 1,119 people developed Alzheimer's disease.

Among the participants taking erectile dysfunction drugs, 749 developed Alzheimer's disease, which corresponds to a rate of 8.1 cases per 10,000 person-years. Person-years represent both the number of people in the study and the amount of time each person spends in the study. Among those who did not take the drugs, 370 developed Alzheimer's disease, which corresponds to a rate of 9.7 cases per 10,000 person-years.

Once researchers adjusted for other factors that could affect the rate of Alzheimer's disease, such as age, smoking status and alcohol consumption, they found that people who took erectile dysfunction drugs were 18% less likely to develop Alzheimer's than people who did not take the drugs.

The association was strongest in those who were issued the most prescriptions over the study period.

"More research is needed to confirm these findings, learn more about the potential benefits and mechanisms of these drugs and look into the optimal dosage," Brauer said. "A randomized, controlled trial with both male and female participants is warranted to determine whether these findings would apply to women as well."

The study was based on prescription records. A limitation of the study is that researchers did not have information on whether participants actually filled the prescriptions and used the drugs.

Source:
Journal reference:

Adesuyan, M., et al. (2024) Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease A Cohort Study. Neurology. doi.org/10.1212/WNL.0000000000209131.

Comments

  1. Anne Barschall Anne Barschall United States says:

    BUT -- couldn't it be the sexual activity, rather than the drugs, that caused the improvement?  After all sexual activity is a form of exercise and neurological stimulation.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation